NovMetaPharma Co., Ltd. (XKON:229500)
9,170.00
+50.00 (0.55%)
At close: Mar 5, 2026
77.03% (1Y)
| Market Cap | 117.37B |
| Revenue (ttm) | 1.30B |
| Net Income (ttm) | 408.03M |
| Shares Out | 12.84M |
| EPS (ttm) | 120.00 |
| PE Ratio | 76.17 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,757 |
| Average Volume | 5,301 |
| Open | 9,200.00 |
| Previous Close | 9,120.00 |
| Day's Range | 8,800.00 - 9,400.00 |
| 52-Week Range | 4,810.00 - 17,890.00 |
| Beta | 0.19 |
| RSI | 25.38 |
| Earnings Date | n/a |